# Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

Source: https://onco.cc/trials/nct07130903/  
OnCo record `nct07130903` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of fruquintinib in colorectal cancer, run by Barbara Ann Karmanos Cancer Institute, now recruiting.

## Summary

Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer is a phase 2, interventional study registered as NCT07130903 by Barbara Ann Karmanos Cancer Institute, with a registry enrolment figure of 102 participants, started 2025-09-10 and due to reach its primary completion in 2028-04-17. Interventions recorded: Fruquintinib; TheraBionic P1. Conditions listed: Metastatic Colorectal Adenocarcinoma. Primary outcome: Overall Survival (OS). Colorectal eligibility wording from the registry: "* Participant must have histologically or cytologically confirmed metastatic colorectal adenocarcinoma". Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT07130903
- Phase: 2
- Setting: A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer
- Sponsor: Barbara Ann Karmanos Cancer Institute
- Enrolled: 102

## Sources

- ClinicalTrials.gov NCT07130903: https://clinicaltrials.gov/study/NCT07130903

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/), [Rectal cancer](https://onco.cc/cancers/rectal-cancer/)
- technologies: [Anti-angiogenic therapy](https://onco.cc/technologies/antiangiogenic/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/), [Thermal ablation (RFA, microwave, cryo)](https://onco.cc/technologies/thermal-ablation/)
- drugs: [Fruquintinib](https://onco.cc/drugs/fruquintinib/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07130903.json